Approvals/TGA/ABRILADA adalimumab 20 mg solution for injection pre-filled syringe

Approved

STANDARD

ABRILADA adalimumab 20 mg solution for injection pre-filled syringe

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2d69ff5e2c6a2026
Product Name: ABRILADA adalimumab 20 mg solution for injection pre-filled syringe
Artg Id: 334496
Artg Name: ABRILADA adalimumab 20 mg solution for injection pre-filled syringe
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2021-02-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f07db8cba67c4b07ca63e8a534e736f4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/58ae2edf739351667cd3d870c97dd4bf.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2d69ff5e2c6a2026

Type

Standard